ClinicalTrials.gg
CompletedNCT06217705Updated Aug 13, 2024

Testing the Effects of Project Calm in Ukrainian Schools

An interventional study of Project Calm in Trauma, Anxiety and Depression, sponsored by Harvard University. Completed at 1 site in United States. Open to participants aged 9 Years to 18 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-08-13.

Sponsored by Harvard University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
728
Allocation
Randomized
Ages
9 Years to 18 Years
Sex
All
01

Study summary

The purpose of this study is to test the effectiveness of a universal, digital, single-session intervention for youth mental health, functioning, and well-being, when implemented with Ukrainian children and adolescents. The intervention teaches well-established procedures that research has shown to be effective in helping American children calm themselves and regulate emotions, including slowed breathing and peaceful mental imagery. The intervention has not been tested previously with Ukrainian students. Participants will be provided access to this brief online program as part of the school curriculum. Students will be randomly assigned to receive the digital program either immediately or after 2 months. This 2-month lag will allow for evaluating the effectiveness of Project Calm in improving students' mental health, well-being, and self-calming skills. This will also allow for evaluating the effectiveness of such an intervention for war-exposed youths for whom these interventions may be especially helpful given the gap between these children's needs for mental health services and the very limited availability of clinicians

Read the detailed description

Russia's invasion of Ukraine has deeply impacted the nation's children, perhaps most strikingly those who remain in Ukraine and are confronted by the trauma of war. 2.5 million have fled their homes, but even those still at home endure explosions, violence, loss of loved ones, and an estimated average of 900 hours hiding in bunkers. Research in Ukraine shows high levels of child mental health (MH) problems, including anxiety, depression, interpersonal stress, and difficulty regulating emotions. PI Weisz works with child MH researchers and clinicians from Ukraine and 5 other countries (the GROW consortium) to plan psychological support for these children. The group has concluded that Ukrainian-language digital MH interventions teaching evidence-based coping skills are the optimum form of early psychological support at this time, given the massive number of war-exposed Ukrainian children, the dearth of professional clinicians, and the ready accessibility of digital devices. Brief digital interventions (BDIs) for MH have been found effective with children in >90 randomized controlled trials (RCTs). They require no professional training or funding, and are easily implemented via digital devices used in nearly all schools. Ukrainian children may be helped via a BDI that teaches them evidence-based procedures for calming themselves when they experience distressing emotions.

The Harvard Lab for Youth Mental Health is collaborating with Ukrainian schools in the Zhytomyr region, which has been repeatedly targeted by Russian missiles since the first month of the invasion, spreading fear throughout the population and destroying airports, residential neighborhoods, hospitals, and at least one school. Children in Zhytomyr experience war-related MH problems identified in Ukrainian research reviews, including anxiety, sadness, and difficulty calming and regulating distressing negative emotions. Students will be offered a BDI that addresses these problems by teaching well-established skills that have robust empirical support: Project Calm teaches children to calm and regulate distressing emotions by using skills such as slowed breathing, relaxing of tense muscles, and peaceful mental imagery. This 30-minute BDI, which has been refined via student and school staff feedback over a 2-year period, is highly rated by children and teens, and has already been accessed >1000 times in North America.

Project Calm will be tested via an RCT with a time-matched, school-related control activity; students will be randomized 50/50 to complete Project Calm after the baseline assessment or after a 2-month lag. Students in grades 4-12 will complete MH, wellbeing, and BDI-skills measures at baseline and 1-, 2-, 3-, and 4-months post-baseline. Data collection will span January - June of 2024. Findings may point the way to a highly scalable, accessible, and disseminable approach to MH support-easily implemented in schools or community settings-that could benefit Ukrainian children and, with translation and adaptation, war-affected children of other nations.

02

Conditions studied

  • Trauma
  • Anxiety
  • Depression
  • Child Behavior
03

In context

Wounds and Injuries

5,085 studies on the registry are indexed under Wounds and Injuries; 849 are open to participants now.

This study's enrollment of 728 is above the median of 52 across 3,261 interventional studies indexed under Wounds and Injuries.

Browse Wounds and Injuries studies →

Lead sponsor

Harvard University is the lead sponsor of 50 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
9 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Youth in grades 4+ at partnering schools for Ukrainian children
  • Youth and at least one guardian consent to adolescent participation in study
  • Youth reads Ukrainian well enough to effectively complete the digital programs
  • Youth has access to a digital device

Exclusion criteria

Exclusion Criteria:

  • Youth does not have access to a digital device
  • Youth has an intellectual disability that precludes comprehension of the program content
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
728 participants (actual)

Study arms

  • Experimental
    Project Calm

    Project Calm is a \~30-minute self-guided digital intervention designed to teach children and adolescents empirically supported emotion regulation skills to facilitate self-calming when faced with intense negative emotions. Project Calm uses vignettes, interactive activities, and engaging graphics to teach youth calming skills.

    Behavioral: Project Calm

  • Other
    Delayed Receipt of Project Calm Control Condition

    No intervention for first two months; will receive Project Calm after 2-months and become a second-wave intervention condition.

    Behavioral: Project Calm

Interventions

  • BehavioralProject Calm

    Project Calm is a \~30-minute self-guided digital intervention designed to teach children and adolescents empirically supported emotion regulation skills to facilitate self-calming when faced with intense negative emotions. Project Calm uses vignettes, interactive activities, and engaging graphics to teach youth calming skills.

06

What researchers measure

Primary outcomes

  1. Change in Behavior and Feelings Survey (Internalizing Subscale)

    Trajectories of self-reported symptoms of anxiety and depression from the 6-item (each item rated on a 0-4 scale, with higher ratings indicating more symptoms) Internalizing subscale of the Behavior and Feelings Survey. Total scores range from 0 to 24, with higher scores indicating more symptoms.

    Time frame: Assessed at baseline, 1-month, 2-month, 3-month, and 4-month follow-ups

  2. Perceived Program Acceptability and Helpfulness

    Post-intervention feedback on the program's perceived acceptability and helpfulness as measured via a 7-item measure, with each item rated on a 1-5 scale, with higher scores indicating greater acceptability and helpfulness.

    Time frame: Assessed immediately post-intervention

Secondary outcomes

  1. Change in Behavior and Feelings Survey (Externalizing Subscale)

    Trajectories of self-reported misbehavior from the 6-item (each item rated on a 0-4 scale, with higher ratings indicating more symptoms) Externalizing subscale of the Behavior and Feelings Survey. Total scores range from 0 to 24, with higher scores indicating more symptoms.

    Time frame: Assessed at baseline, 1-month, 2-month, 3-month, and 4-month follow-ups

  2. Emotion Regulation Mechanisms of Change Questions

    Emotion Regulation Mechanisms of Change Questions - Assessed at all time points via a novel 3-item measure (0-10 scale) evaluating participants' calming skills. Specific items include: * When I feel tense or nervous, I can calm myself. * When I feel scared, I can calm myself. * When I feel angry, I can calm myself.

    Time frame: Assessed at baseline, 1-month, 2-month, 3-month, and 4-month follow-ups

  3. Youth Top Problems

    Assessed via the Youth Top Problems Assessment (Herren et al., 2018). Items are rated on a scale from 0 (not a problem at all) to 4 (a very big problem).

    Time frame: Assessed at baseline

  4. Peabody Treatment Progress Battery's Life Satisfaction Scale

    Assessed via the Peabody Treatment Progress Battery's Life Satisfaction Scale. Items are rated on a scale from 1 (very dissatisfied) to 5 (very satisfied).

    Time frame: Assessed at baseline, 1-month, 2-month, 3-month, and 4-month follow-ups

  5. Treatment Expectancy Questions

    Treatment expectations will be assessed at pre-intervention via a novel 4-item measure (0-10 scale) evaluating participants' expectations of intervention effects.

    Time frame: Assessed immediately pre-intervention

  6. Sensitivity

    Assessed at all time points via the Highly Sensitive Person Scale (Baryla-Matejczuk et al., 2022). Items are rated on a scale from 1 (not at all) to 7 (definitely).

    Time frame: Assessed at baseline, 1-month, 2-month, 3-month, and 4-month follow-ups

  7. Trauma Symptoms

    Assessed at all time points via the Short Post-Traumatic Stress Disorder Rating Interview (SPRINT-10; Connor \& Davidson, 2001). Items are rated on a scale from 0 (not at all) to 4 (very much).

    Time frame: Assessed at baseline, 1-month, 2-month, 3-month, and 4-month follow-ups]

07

Study locations

1 site
  • Harvard University
    Cambridge, Massachusetts 02138, United States
08

References and documents

Publications

  • Steinberg JS, Sun J, Venturo-Conerly KE, Sood G, Mair P, Davydenko O, Porzak R, Ougrin D, Weisz JR. Randomized trial testing a self-guided digital mental health intervention teaching calming skills for Ukrainian children. Npj Ment Health Res. 2025 May 16;4(1):20. doi: 10.1038/s44184-025-00134-w. PubMed 40379908 ↗

Individual participant data

Plan to share: Undecided — Analytic code will be made available upon publication of trial results. Study protocol and statistical plan are available on Open Science Framework.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2024 to primary completion in Jun 2024, 5 months.

Of 1,289 non-industry interventional studies with no phase under Wounds and Injuries, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 44. This study's 5 months is below that.

Counting every sponsor, half of 1,394 studies reached it within 21 months; a quarter within 9 and three quarters within 43.

Wounds and Injuries covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 12, 2024
First posted
Jan 22, 2024
StartActual
Jan 16, 2024
Primary completionActual
Jun 16, 2024
CompletionActual
Jul 30, 2024
Last update
Aug 13, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 13, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06217705
Lead sponsor
Harvard University
Collaborators
John Weisz
Responsible party
John Weisz (Professor, Harvard University) — Principal investigator
First posted
Jan 22, 2024
Start date
Jan 16, 2024
Primary completion
Jun 16, 2024
Completion
Jul 30, 2024
Last update
Aug 13, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion